ALGS
Aligos Therapeutics Inc
Price:  
9.16 
USD
Volume:  
79,665.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Aligos Relative Valuation

-2134.1%
Upside

As of 2025-07-19, the Relative Valuation of Aligos Therapeutics Inc (ALGS) is (186.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.16 USD, the upside of Aligos Therapeutics Inc based on Relative Valuation is -2134.1%.

The range of the Relative Valuation is (117.68) - (232.74) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.0x - 26.7x 19.8x
Forward P/E multiples 13.5x - 32.3x 22.9x
Fair Price (117.68) - (232.74) (186.32)
Upside -1384.7% - -2640.8% -2134.1%
9.16 USD
Stock Price
(186.32) USD
Fair Price

Aligos Relative Valuation - Historical P/E Data

Date P/E
2025-07-17 -1.04
2025-07-16 -1.00
2025-07-15 -0.98
2025-07-14 -1.00
2025-07-11 -0.96
2025-07-10 -1.01
2025-07-09 -0.99
2025-07-08 -0.95
2025-07-07 -0.86
2025-07-03 -0.90
2025-07-02 -0.84
2025-07-01 -0.85
2025-06-30 -0.83
2025-06-27 -0.83
2025-06-26 -0.82
2025-06-25 -0.88
2025-06-24 -0.95
2025-06-23 -0.82
2025-06-20 -0.87
2025-06-18 -0.96
2025-06-17 -0.86
2025-06-16 -0.92
2025-06-13 -0.88
2025-06-12 -0.92
2025-06-11 -0.91
2025-06-10 -0.84
2025-06-09 -0.82
2025-06-06 -0.83
2025-06-05 -0.69
2025-06-04 -0.72
2025-06-03 -0.68
2025-06-02 -0.60
2025-05-30 -0.61
2025-05-29 -0.66
2025-05-28 -0.66
2025-05-27 -0.64
2025-05-23 -0.63
2025-05-22 -0.65
2025-05-21 -0.65
2025-05-20 -0.70
2025-05-19 -0.68
2025-05-16 -0.67
2025-05-15 -0.67
2025-05-14 -0.64
2025-05-13 -0.68
2025-05-12 -0.65
2025-05-09 -0.51
2025-05-08 -0.56
2025-05-07 -0.50
2025-05-06 -0.53